TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD

Otros idiomas Tianjin Chase Sun Pharmaceutical Co.,Ltd

Acciones

300026

CNE100000GF1

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
3,86 ^CNY	+1,58 %		+4,32 %	-8,96 %

01/03	El beneficio de 2023 de Tianjin Chase Sun Pharmaceutical cae un 15% por la debilidad de los ingresos	MT
29/02	Tianjin Chase Sun Pharmaceutical Co.,Ltd informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023	29/03
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	01/03
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Tianjin Chase Sun Pharma’s Muscle Relaxant Passes Drug Consistency Test	22/09/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for A Shares for the Year 2022, Payable on 12 May 2023	08/05/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2022	25/04/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2022	31/03/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 19, 2022	12/05/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021	22/04/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021	31/03/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	28/02/22
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tianjin Chase Sun Pharmaceutical Co.,Ltd

Acciones

300026

CNE100000GF1

Otros idiomas

Filtros